Methotrexate offers a better treatment profile than cyclosporin for long-term control of moderate-to-severe atopic dermatitis, shows a comparison study of two first-line immunosuppressive treatments.
Skin can act as a window to a patient’s general health says a physician writing in the journal Medicine. Changes in the skin can signal underlying disease from lupus to gastrointestinal disease.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%